Tuniu to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 14, 2025
2025-02-27
IDOPRESS
NANJING,China,Feb. 26,2025 -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"),a leading online leisure travel company in China,today announced that it plans to release its unaudited financial results for the fourth quarter and fiscal year ended December 31,2024,before the market opens on March 14,2025.
Tuniu's management will hold an earnings conference call at 8:00 am U.S. Eastern Time on March 14,2025 (8:00 pm Beijing/Hong Kong Time on March 14,2025).
Listeners may access the call by dialing the following numbers:
US
1-888-346-8982
Hong Kong
852-301-84992
Mainland China
4001-201203
International
1-412-902-4272
Conference ID: Tuniu 4Q 2024 Earnings Conference Call
A telephone replay will be available one hour after the end of the conference call through March 21,2025. The dial-in details are as follows:
US
1-877-344-7529
International
1-412-317-0088
Replay Access Code: 2263052
Additionally,a live and archived webcast of this conference call will be available at http://ir.tuniu.com/.
About Tuniu Corporation
Tuniu (Nasdaq:TOUR) is a leading online leisure travel company in China that offers integrated travel service with a large selection of packaged tours,including organized and self-guided tours,as well as travel-related services for leisure travelers through its website tuniu.com and mobile platform. Tuniu provides one-stop leisure travel solutions and a compelling customer experience through its online platform and offline service network,including a dedicated team of professional customer service representatives,24/7 call centers,extensive networks of offline retail stores and self-operated local tour operators. For more information,please visit http://ir.tuniu.com.
Newest
-
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
-
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
-
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
-
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
